CurrentEndo
Get Weekly

CurrentEndo coverage · page 23 of 55

Diabetes, Obesity and Metabolism

Briefs 881–920 of 2,200 CurrentEndo has covered from this journal, newest publication first

Latest from Diabetes, Obesity and Metabolism

All coverage, newest first

  1. Diabetes Obes Metab

    Efficacy and safety in tirzepatide‐treated Korean adults with type 2 diabetes—A post hoc analysis of SURPASS ‐ AP ‐combo and SURPASS ‐3

    Secondary analysisT2D & other

  2. Diabetes Obes Metab

    Joint trajectories of skeletal muscle and fat mass in relation to glucose homeostasis: 6‐Year findings from adults aged ≥50 years

    Cohort studyT2D & other

  3. Diabetes Obes Metab

    Blood glucose trajectories in diabetes patients receiving CAPDCA model of personalised patient education: A cluster randomised controlled trial

    Randomized controlled trialT2D & other

  4. Diabetes Obes Metab

    Validation of anthropometric and bioelectrical impedance equations for the prediction of fat mass amongst South African children

    Cross-sectional studyObesity

  5. Diabetes Obes Metab

    Effects of estetrol/drospirenone versus ethinyl estradiol/drospirenone on glucose tolerance in women with polycystic ovary syndrome: A randomised controlled trial

    Randomized controlled trialReproductive endocrine

  6. Diabetes Obes Metab

    Efficacy of GLP ‐1 receptor agonists in patients with obesity and heart failure with preserved ejection fraction: A systematic review and meta‐analysis of randomised controlled trials

    Meta-analysisObesity

  7. Diabetes Obes Metab

    Sex differences in the efficacy of GLP ‐1 receptor agonists: A systematic review and meta‐analysis of cardiovascular and renal outcome trials

    Meta-analysisComplications

  8. Diabetes Obes Metab

    Impact of SGLT2 inhibitors on the risk of age‐related ocular diseases in patients with type 2 diabetes mellitus: A target trial emulation study

    Cohort studyT2D & other

  9. Diabetes Obes Metab

    Comparative efficacy and safety of Glucagon‐like pepetide‐1 receptor agonists with metformin in Asian versus non‐Asian patients with type 2 diabetes: A systematic review and meta‐analysis

    Meta-analysisT2D & other

  10. Diabetes Obes Metab

    Obesity is associated with increased brain glucose uptake and activity but not neuroinflammation ( TSPO availability) in monozygotic twin pairs discordant for BMI —Exercise training reverses increased brain activity

    Research articleObesity

  11. Diabetes Obes Metab

    The healthcare and economic burden associated with inadequate risk factor control for type 2 diabetes in Hong Kong: A population‐based modelling study

    Cohort studyT2D & other

  12. Diabetes Obes Metab

    Cardiovascular risk reduction with glucagon‐like peptide‐1 receptor agonists is proportional to HbA1c lowering in type 2 diabetes: An updated meta‐regression analysis incorporating FLOW and SOUL trials

    Meta-analysisT2D & other

  13. Diabetes Obes Metab

    Hypoglycemia incidence and behavioural adjustments during free‐living unstructured physical activity in adults with type 1 diabetes using AID systems: Results from the RAPPID study

    Cohort studyTechnology

  14. Diabetes Obes Metab

    Long‐term efficacy and safety of tirzepatide in participants with type 2 diabetes with inadequate glycaemic control on metformin and/or sulfonylurea: Post‐hoc analysis of SURPASS ‐4

    Secondary analysisT2D & other

  15. Diabetes Obes Metab

    Lower risk of cardiovascular events in patients initiated on semaglutide 2.4 mg in the real‐world: Results from the SCORE study (Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity in the Real World)

    Cohort studyObesity

  16. Diabetes Obes Metab

    Investigating multimorbidity trajectories in people living with MASLD diagnosis: A trajectory analysis using the UK Biobank

    Cohort studyLipids & liver

  17. Diabetes Obes Metab

    Optimal type and dose of exercise to improve glycated haemoglobin in individuals with type 1 diabetes: A systematic review and Bayesian dose–response network meta‐analysis of RCTs

    Meta-analysisT1D

  18. Diabetes Obes Metab

    Subjective smell‐ and taste loss in diabetes—A questionnaire‐based study on 47 011 individuals with diabetes and matched controls

    Cross-sectional studyT2D & other

  19. Diabetes Obes Metab

    Clinical characteristics and outcomes of diabetes‐related ketoacidosis ( DKA ) in sodium‐glucose co‐transporter‐2 inhibitor ( SGLT2i ) users with type 2 diabetes

    Meta-analysisT2D & other

  20. Diabetes Obes Metab

    Sex and Body Mass Index differences in the incidence of vascular and cardiometabolic diseases: A retrospective cohort study including 233 730 patients in Germany

    Cohort studyObesity

  21. Diabetes Obes Metab

    Declining incidence of hypoglycaemia in diabetes secondary to chronic pancreatitis: A nationwide cohort study from 2003 to 2022

    Cohort studyComplications

  22. Diabetes Obes Metab

    Appetite, eating attitudes, and eating behaviours during treatment with retatrutide in adults with type 2 diabetes: Results of a phase 2 study

    Secondary analysisT2D & other

  23. Diabetes Obes Metab

    Efficacy and safety of survodutide on glycemic control and weight loss in adults: A systematic review and meta‐analysis

    Meta-analysisT2D & other

  24. Diabetes Obes Metab

    Olfactory training improves cognition and modifies brain networks in type 2 diabetes patients with mild cognitive impairment: A 16‐week randomised controlled trial

    Randomized controlled trialT2D & other

  25. Diabetes Obes Metab

    Identification of subtypes of type 2 diabetes in the Chinese population and their distinct complication risk profiles

    Cohort studyT2D & other

  26. Diabetes Obes Metab

    Pharmacokinetics and pharmacodynamics of oral insulin ( ORMD ‐0801) in healthy subjects: A phase I study using hyperinsulinaemic‐euglycaemic clamp

    Randomized controlled trialT2D & other

  27. Diabetes Obes Metab

    Early insulin degludec with continuous intravenous insulin infusion in the management of diabetic ketoacidosis: A randomized controlled trial

    Randomized controlled trialT1D

  28. Diabetes Obes Metab

    Physical activity substitution: An overlooked constraint on energy expenditure during exercise and physical activity interventions

    Research article

  29. Diabetes Obes Metab

    Treat to target in weight management with semaglutide: Real‐world evidence from an eHealth clinic

    Cohort studyObesity

  30. Diabetes Obes Metab

    Weight loss interventions and obesity‐associated cancers in people with type 2 diabetes and overweight/obesity: A real‐world observational study

    Cohort studyObesity

  31. Diabetes Obes Metab

    Assessing the effects of naltrexone‐bupropion on hepatic steatosis and fibrosis in patients with T2DM and overweight or obesity: Insights from a placebo‐controlled trial

    Secondary analysisObesity

  32. Diabetes Obes Metab

    Beyond BMI : The role of diabetes and central obesity in fracture risk—Insights from the UK biobank

    Cohort studyBone & mineral

  33. Diabetes Obes Metab

    Barriers to adoption of biosimilar insulins in Europe: A mixed‐methods study

    Research articleT2D & other

  34. Diabetes Obes Metab

    Baseline clinical factors associated with diabetes distress in dialysis patients: Insights from the ABCD audit data

    Cross-sectional studyT2D & other

  35. Diabetes Obes Metab

    Raised levels of Interleukin‐8 and myeloperoxidase in patients with recent onset type 1 diabetes

    Case-control studyT1D

  36. Diabetes Obes Metab

    Relationship of intra‐pancreatic fat deposition with low‐density lipoprotein subfractions and hepatic lipase

    Cross-sectional studyLipids & liver

  37. Diabetes Obes Metab

    Integrative proteomic analysis provides novel therapeutic insights for etiological subtypes of diabetes

    Research articleT2D & other

  38. Diabetes Obes Metab

    Proteomics‐enabled learning machine algorithms enhance the prediction of cardiovascular diseases in patients with type 2 diabetes mellitus

    Diagnostic or prognostic studyT2D & other

  39. Diabetes Obes Metab

    Impact of onset age of type 2 diabetes mellitus on risk of renal complications compared to age‐matched non‐diabetic patients: Two cohort studies in the United Kingdom and Hong Kong

    Cohort studyT2D & other

  40. Diabetes Obes Metab

    Trends in mortality and hospitalisations for cardiovascular, kidney and liver disease in people with type 2 diabetes in England, 2009–2019

    Cohort studyT2D & other

All 2,200 Briefs in ExploreShowing Briefs 881–920 of 2,200, newest first